Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby

• US 8,921,047 B2
• Filed: 10/29/2012
• Issued: 12/30/2014
• Est. Priority Date: 06/26/2001
• Status: Expired due to Fees

• Current Assignee: Ibis Biosciences Incorporated
• Original Assignee: Ibis Biosciences Incorporated
• Inventors: Ecker, David J., Griffey, Richard H., Sampath, Rangarajan, Hofstadler, Steven A., McNeil, John, Crooke, Stanley T.
• Primary Examiner(s): Benzion, Gary
• Assistant Examiner(s): BICKNELL, DANNA E
• Application Number:
  US13/663,176
• Publication Number:
  US 20130124099A1
• Time in Patent Office: 792 Days
• Field of Search: None
• US Class Current: 435/6.12
• CPC Class Codes: G16B 15/00 ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
• CPC Class Codes: G16B 15/10 Nucleic acid folding
• CPC Class Codes: G16B 20/00 ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
• CPC Class Codes: G16B 20/20 Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
• CPC Class Codes: G16B 40/10 Signal processing, e.g. from mass spectrometry [MS] or from PCR
• CPC Class Codes: G16B 50/00 ICT programming tools or database systems specially adapted for bioinformatics
• CPC Class Codes: G16B 99/00 Subject matter not provided for in other groups of this subclass
• CPC Class Codes: G16H 50/80 for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
• CPC Class Codes: Y02A 90/10 Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Abstract

The present invention relates generally to the field of investigational bioinformatics and more particularly to secondary structure defining databases. The present invention further relates to methods for interrogating a database as a source of molecular masses of known bioagents for comparing against the molecular mass of an unknown or selected bioagent to determine either the identity of the selected bioagent, and/or to determine the origin of the selected bioagent. The identification of the bioagent is important for determining a proper course of treatment and/or irradication of the bioagent in such cases as biological warfare. Furthermore, the determination of the geographic origin of a selected bioagent will facilitate the identification of potential criminal identity.

Claims

1. A method for providing bioagent characterizing information comprising:

a) measuring or calculating with a mass spectrometer a plurality of molecular masses corresponding to a plurality of amplification products wherein the amplification products are obtained by amplification of at least one target sequence region of a bioagent nucleic acid gene sequence using a primer pair that hybridizes to the at least one target sequence region of a plurality of bioagents;

said target sequence region comprising two conserved regions wherein a first conserved region is hybridizable with a first primer of the primer pair and a second conserved region is hybridizable with a second primer of the primer pair, and wherein the two conserved regions flank a variable region that uniquely varies between said plurality of bioagents;

b) interrogating a database stored on a computer readable medium with an identification query, wherein said identification query comprises comparison of the measured molecular mass data of step a) with said database;

said database comprising molecular masses calculated or measured for the target sequence regions for a plurality of bioagents and each of the calculated or measured molecular masses is indexed to bioagent characterizing information; and

c) delivering from said database a response comprising bioagent characterizing information generated by the comparison of said measured molecular masses of step a) and said calculated or measured molecular masses of step b) thereby identifying a bioagent associated with an amplification product of step a).

2. The method of claim 1 wherein the nucleic acid gene sequence encodes ribosomal RNA or a protein involved in translation, replication, recombination, repair, transcription, nucleotide metabolism, amino acid metabolism, lipid metabolism, energy generation, uptake, or secretion.

3. The method of claim 1 wherein the bioagent characterizing information is a genus name.

4. The method of claim 3 wherein the genus name is Acinetobacter, Aeromonas, Bacillus, Bacteroides, Bartonella, Bordetella, Borrelia, Brucella, Burkholderia, Campylobacter, Chlamydia, Chlamydophila, Clostridium, Coxiella, Enterococcus, Escherichia, Francisella, Fusobacterium, Haemophilus, Helicobacter, Klebsiella, Legionella, Leptospira, Listeria, Moraxella, Mycobacterium, Mycoplasma, Neisseria, Proteus, Pseudomonas, Rhodobacter, Rickettsia, Salmonella, Shigella, Staphylococcus, Streptobacillus, Streptomyces, Treponema, Ureaplasma, Vibrio, or Yersinia.

5. The method of claim 1 wherein the bioagent characterizing information is a species name.

6. The method of claim 1 wherein the bioagent characterizing information is a strain name.

7. The method of claim 1 wherein said mass spectrometer is an electrospray Fourier transform ion cyclotron resonance mass spectrometer or an electrospray time-of-flight mass spectrometer.

8. The method of claim 1 wherein the primer pair comprises at least one modified nucleobase.

9. The method of claim 8 wherein the modified nucleobase comprises 2,6-diaminopurine, propyne C, propyne T, phenoxazine, or G-clamp.

10. The method of claim 1 wherein said bioagent is a biological warfare agent.

11. The method of claim 10 wherein the biological warfare agent comprises Bacillus anthracis, Yersinia pestis, Franciscella tularensis, Brucella suis, Brucella abortus, Brucella melitensis, Burkholderia mallei, Burkholderia pseudomallei, Salmonella typhi, Rickettsia typhi, Rickettsia prowasekii, Coxiella burnetii, Rhodobacter capsulatus, Chlamydia pneumoniae, Escherichia coli, Shigella dysenteriae, Shigella flexneri, Bacillus cereus, Clostridium botulinum, Pseudomonas aeruginosa, Legionella pneumophila, or Vibrio cholerae.

12. The method of claim 1 wherein said bioagent is a bacterium, virus, fungus or protozoan.

13. The method of claim 12 wherein the bioagent is arenavirus, bunyavirus, mononegavirales, picornavirus, astrovirus, calicivirus, nidovirales, flavivirus or togavirus.